$Pasithea Therapeutics Corp.(KTTA)$ Bought the pump hoping for an AH squeeze. It didn't happen. So decided to actually check the company. Financials are not awful. Pre-revenue company with 20.5 million cash and 1.5 million loss last quarter. That's enough cash for a couple of quarters. And a brand new FDA approval, which will boost sales. I am very comfortable averaging down and holding for a couple of months.
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
2
举报
登录后可参与评论
暂无评论